Literature DB >> 7615731

Comparison of phenotypic characteristics, DNA-DNA hybridization results, and results with a commercial rapid biochemical and enzymatic reaction system for identification of viridans group streptococci.

K Kikuchi1, T Enari, K Totsuka, K Shimizu.   

Abstract

The rapid ID 32 Strep system (bioMérieux, Marcy l'Etoile, France) was evaluated for its ability to identify 21 species of viridans group streptococci; results were compared with DNA-DNA hybridization results and results of conventional physiological tests. A total of 171 strains of the 21 species including 147 clinical strains was analyzed. Of the 156 strains of species included in the database of this system, 136 strains (87%) were correctly identified. Incorrect identification occurred for 13 strains (8%), and no identification was given for 7 strains (5%). It was difficult to differentiate S. mitis and S. oralis accurately with this system. Of the 17 strains identified as S. mitis by the rapid ID 32 Strep system, the results of DNA-DNA hybridization were in agreement for only 3 strains. S. crista and S. parasanguis, which are not included in the database, were identified as S. mitis or S. sanguis or were not identified, but S. parasanguis could probably be identified by using the rapid ID 32 Strep system because the biochemical profile is well characterized for this species. The rapid ID 32 Strep system can be used to differentiate most species for which phenotypic characteristics have been described if the database is revised according to recently reported amended criteria for the identification of viridans group streptococci. However, identification of a few species such as S. mitis and S. oralis is problematic with this system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615731      PMCID: PMC228134          DOI: 10.1128/jcm.33.5.1215-1222.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Comparison of API Rapid Strep, Baxter MicroScan Rapid Pos ID Panel, BBL Minitek Differential Identification System, IDS RapID STR System, and Vitek GPI to conventional biochemical tests for identification of viridans streptococci.

Authors:  C J Hinnebusch; D M Nikolai; D A Bruckner
Journal:  Am J Clin Pathol       Date:  1991-10       Impact factor: 2.493

2.  Intrageneric structure of Streptococcus based on comparative analysis of small-subunit rRNA sequences.

Authors:  R W Bentley; J A Leigh; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1991-10

Review 3.  Classification and identification of the viridans streptococci.

Authors:  A L Coykendall
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

4.  Viridans streptococcal endocarditis: clinical, microbiological, and echocardiographic correlations.

Authors:  J I Sussman; E J Baron; M J Tenenbaum; M H Kaplan; J Greenspan; R R Facklam; M B Tyburski; M A Goldman; B F Kanzer; R A Pizzarello
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

5.  A scheme for the identification of viridans streptococci.

Authors:  D Beighton; J M Hardie; R A Whiley
Journal:  J Med Microbiol       Date:  1991-12       Impact factor: 2.472

6.  Incidence of penicillin tolerance among blood culture isolates of Streptococcus sanguis, 1987-88.

Authors:  P A James; S E Young; D G White
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

7.  Accuracy and reproducibility of the IDS rapID STR system for species identification of streptococci.

Authors:  P C Appelbaum; M R Jacobs; W M Palko; E E Frauenhoffer; A Duffett
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

8.  Comparative evaluation of the API 20S and AutoMicrobic gram-positive identification systems for non-beta-hemolytic streptococci and aerococci.

Authors:  R Facklam; G S Bosley; D Rhoden; A R Franklin; N Weaver; R Schulman
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

9.  Streptococcus crista sp. nov., a viridans streptococcus with tufted fibrils, isolated from the human oral cavity and throat.

Authors:  P Handley; A Coykendall; D Beighton; J M Hardie; R A Whiley
Journal:  Int J Syst Bacteriol       Date:  1991-10

10.  Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species.

Authors:  R A Whiley; D Beighton
Journal:  Int J Syst Bacteriol       Date:  1991-01
View more
  23 in total

1.  All detectable high-molecular-mass penicillin-binding proteins are modified in a high-level beta-lactam-resistant clinical isolate of Streptococcus mitis.

Authors:  A Amoroso; D Demares; M Mollerach; G Gutkind; J Coyette
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Identification of clinically relevant viridans group streptococci by sequence analysis of the 16S-23S ribosomal DNA spacer region.

Authors:  Chao Chien Chen; Lee Jene Teng; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  Comparison of conventional and molecular methods for identification of aerobic catalase-negative gram-positive cocci in the clinical laboratory.

Authors:  P P Bosshard; S Abels; M Altwegg; E C Böttger; R Zbinden
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

4.  Array-based identification of species of the genera Abiotrophia, Enterococcus, Granulicatella, and Streptococcus.

Authors:  Sheng Kai Tung; Lee Jene Teng; Mario Vaneechoutte; Hung Mo Chen; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

5.  Identification of clinically relevant viridans group streptococci to the species level by PCR.

Authors:  F Garnier; G Gerbaud; P Courvalin; M Galimand
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

6.  Mannosidase production by viridans group streptococci.

Authors:  K A Homer; G Roberts; H L Byers; E Tarelli; R A Whiley; J Philpott-Howard; D Beighton
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

7.  Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.

Authors:  M J Ferrándiz; J Oteo; B Aracil; J L Gómez-Garcés; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

8.  Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci.

Authors:  I González; M Georgiou; F Alcaide; D Balas; J Liñares; A G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

9.  groESL sequence determination, phylogenetic analysis, and species differentiation for viridans group streptococci.

Authors:  Lee-Jene Teng; Po-Ren Hsueh; Jui-Chang Tsai; Pin-Wun Chen; Jia-Chuan Hsu; Hsin-Chih Lai; Chun-Nan Lee; Shen-Wu Ho
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Late Established Mutans Streptococci in Children over 3 Years Old.

Authors:  Mitsugi Okada; Yoshiko Taniguchi; Fumiko Hayashi; Takako Doi; Junji Suzuki; Motoyuki Sugai; Katsuyuki Kozai
Journal:  Int J Dent       Date:  2010-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.